Renin-Angiotensin System Gene Polymorphisms, Blood Pressure,Dyslipidemia, and Diabetes in Hong Kong Chinese [PDF]
, 2001 G. Neil Thomas +5 more
openalex +1 more source
Nutrigenetics and Dyslipidemia [PDF]
, 2012 Dyslipidemia is an abnormal amount of lipids (abnormality in any of the lipoprotein fractions), especially elevated Low Density Lipoprotein (LDLs) and decreased High Density Lipoprotein (HDLs) in the blood (Shalileh et al., 2009). In developed countries, most dyslipidemias are hyperlipidemias; that is, an elevation of lipids in the blood, are often due
openaire +3 more sources
Mutation of the RIIβ Subunit of Protein Kinase A Prevents Diet-Induced Insulin Resistance and Dyslipidemia in Mice [PDF]
, 2001 Sandra A. Schreyer +3 more
openalex +1 more source
The contribution of GWAS loci in familial dyslipidemias [PDF]
, 2016 et al.,, Wilson, Richard K
core +2 more sources
Critical appraisal of laropiprant and extended-release niacin combination in the management of mixed dyslipidemias and primary hypercholesterolemia [PDF]
, 2010 Niacin is a B-complex vitamin which has been used for decades for the management of mixed dyslipidemias and primary hypercholesterolemia. It decreases the risk of cardiovascular events either when used as a monotherapy or in combination with other lipid ...
Hussein, Ayman A, Nicholls, Stephen J
core +2 more sources
Levels of soluble cell adhesion molecules in patients with dyslipidemia
, 1996 Anne M. Hackman +7 more
openalex +1 more source
Hyperinsulinemia, glucose intolerance, and dyslipidemia induced by acute inhibition of phosphoinositide 3-kinase signaling in the liver [PDF]
, 2002 Kazuaki Miyake +5 more
openalex +2 more sources
Management of dyslipidemias with fibrates, alone and in combination with statins: role of delayed-release fenofibric acid [PDF]
, 2010 Cardiovascular disease (CVD) represents the leading cause of mortality worldwide. Lifestyle modifications, along with low-density lipoprotein cholesterol (LDL-C) reduction, remain the highest priorities in CVD risk management. Among lipid-lowering agents,
Elisaf, Moses S +3 more
core +2 more sources
Incidence of dyslipidemia and hyperinsulinemia in women diagnosed with polycystic ovary syndrome (PCOS). [PDF]
, 2001 S.D Scharnowski, D.A. Minjarez
openalex +1 more source